🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study, the investigators will use Tislelizumab combined with LM-302...
Status
Recruiting
Location
Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Start Date
2026-04-21
Trial ID
NCT07569068
Treatments Being Tested
The clinical trial aims to assess the efficacy and safety of Tislelizumab c...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-12-01
Trial ID
NCT06682182
Treatments Being Tested
The purpose of this observational study is to evaluate the impact of differ...
Status
Completed
Location
Jiangsu Cancer Hospital
Start Date
2019-11-01
Trial ID
NCT07098104
Treatments Being Tested
To evaluate the clinical efficacy and safety of Tislelizumab combined with ...
Status
Completed
Location
Fujian cancer hospital
Start Date
2021-10-31
Trial ID
NCT05223088
Treatments Being Tested
This is a phase II open-label study to evaluate the efficacy and safety of ...
Status
Not Yet Recruiting
Location
Xijing Hospital, Air Force Medical University
Start Date
2026-07
Trial ID
NCT07685704
Treatments Being Tested
This study is a prospective, multi-cohort clinical trial designed to evalua...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-15
Trial ID
NCT07243938
The aim of this study is to test the efficacy and safety of immunotherapy p...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2023-05-17
Trial ID
NCT06451211
Treatments Being Tested
This study is a single-center, prospective, phase II clinical trial aimed a...
Status
Recruiting
Location
Wuhan Union Hospital
Start Date
2025-02-15
Trial ID
NCT06685887
Treatments Being Tested
Perioperative chemotherapy improves overall survival (OS) and disease-free ...
Status
Unknown
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2021-12-01
Trial ID
NCT04819971
Treatments Being Tested
For peritoneal metastatic gastric/gastroesophageal junction adenocarcinoma ...
Status
Active Not Recruiting
Location
Fudan University Shanghai Cancer Hospital
Start Date
2025-04-15
Trial ID
NCT06914687
Treatments Being Tested